MichaelLucaDurandoMD

Oncology • Tucson, AZ

Hematologic Oncology

Physician

Join to view full profile

Dr. Durando is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Durando's full profile

Already have an account?

Office
3838 N Campbell Ave
Tucson, AZ 85719
Phone+1 617-818-3441
Is this information wrong?

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2017 - 2021
Penn MedicinePost-Doctoral Fellowship, Molecular Biology, Immunology, and Gene Therapy, 2018 - 2019
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2016 - 2017
Emory University School of MedicineInternship, Internal Medicine, 2015 - 2016
University of North Carolina at Chapel Hill School of MedicineClass of 2015

Certifications & Licensure

UT State Medical License 2021 - 2026
NM State Medical License 2022 - 2026
AZ State Medical License 2021 - 2025
PA State Medical License 2019 - 2024
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma.
Michael Durando, Ajay K Gopal, Joseph Tuscano, Daniel Persky> ;The Oncologist. 2024 Apr 4
3 citations
Four-Year Disease-Free Remission in a Patient With POLE Mutation-Associated Colorectal Cancer Treated Using Anti-PD-1 Therapy.
Michael L Durando, Sanjay V Menghani, Jessica L Baumann, Danny G Robles, Tovah A Day, Cyrus Vaziri, Aaron J Scott> ;Journal of the National Comprehensive Cancer Network. 2022 Mar 1
161 citations
CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
Marcelo G. Kazanietz, Michael Durando, Mariana Cooke> ;Frontiers in Endocrinology. 2019 Jul 12
26 citations
Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury.
Michael Durando, Hannah Tiu, James Soo Kim> ;American Journal of Kidney Diseases. 2017 Dec 1
46 citations
DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress.
Yang Yang, Yanzhe Gao, Liz Mutter-Rottmayer, Anastasia Zlatanou, Michael Durando, Weimin Ding, David W. Wyatt, Dale A. Ramsden, Yuki Tanoue, Satoshi Tateishi, Cyrus Va...> ;The Journal of Cell Biology. 2017 Oct 2
69 citations
A non-catalytic role of DNA polymerase η in recruiting Rad18 and promoting PCNA monoubiquitination at stalled replication forks
Michael Durando, Satoshi Tateishi, Cyrus Vaziri> ;Nucleic Acids Research. 2013 Mar 1
24 citations
Cell cycle stage-specific roles of Rad18 in tolerance and repair of oxidative DNA damage
Yang Yang, Michael Durando, Stephanie L. Smith-Roe, Chris Sproul, Alicia Greenwalt, William K. Kaufmann, Sehyun Oh, Eric A. Hendrickson, Cyrus Vaziri> ;Nucleic Acids Research. 2013 Feb 1
20 citations
c-Jun N-terminal kinase–mediated Rad18 phosphorylation facilitates Polη recruitment to stalled replication forks
Laura R. Barkley, Komaraiah Palle, Michael Durando, Tovah A. Day, Aditi U. Gurkar, Naoko Kakusho, Jianying Li, Hisao Masai, Cyrus Vaziri> ;Molecular Biology of the Cell. 2012 May 15
19 citations
Kinetics and mechanism for the reaction of hexafluoroacetylacetone with CuO in supercritical carbon dioxide.
Michael L. Durando, Rachel Morrish, Anthony J. Muscat> ;Journal of the American Chemical Society. 2008 Nov 17
Join now to see all

Grant Support

Regulatory Signaling in Repair of Environmentally Induced DNA DamageNIEHS2010–2015

Hospital Affiliations

Philadelphia Veterans Affairs Medical CenterPhiladelphia, Pennsylvania
Utah Valley HospitalProvo, Utah
Holy Cross Hospital - Jordan ValleyWest Jordan, Utah
Lakeview HospitalBountiful, Utah
Gila Regional Medical CenterSilver City, New Mexico